Yakira Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,250
Closed -$55K 279
2020
Q3
$55K Hold
14,250
0.02% 218
2020
Q2
$55K Hold
14,250
0.02% 142
2020
Q1
$46K Hold
14,250
0.02% 131
2019
Q4
$69K Hold
14,250
0.02% 133
2019
Q3
$94K Buy
+14,250
New +$79.3K 0.03% 127
2018
Q4
Sell
-150,000
Closed -$1.52M 133
2018
Q3
$1.52M Hold
150,000
0.29% 69
2018
Q2
$1.5M Hold
150,000
0.37% 59
2018
Q1
$1.5M Hold
150,000
0.34% 54
2017
Q4
$1.49M Hold
150,000
0.48% 41
2017
Q3
$1.5M Buy
+150,000
New +$1.49M 0.5% 47

Other funds holding ORGO

Yakira Capital Management's ORGO Position: Q4 2020 in Review

Yakira Capital Management sold out of Organogenesis Holdings (ORGO) in Q4 2020, closing a stake of 14,250 shares — an estimated $55K sold.

Yakira Capital Management first reported a position in ORGO in Q3 2017 and held it in 10 quarters. The position peaked at $1.52M in Q3 2018. 67 funds tracked by Wall St. Rank hold ORGO as of Q4 2020.

  • Yakira Capital Management reported no remaining Organogenesis Holdings position as of Q4 2020 after selling out during the quarter.
  • Yakira Capital Management sold 14,250 Organogenesis Holdings shares in Q4 2020, an estimated $55K.
  • Yakira Capital Management first reported a position in Organogenesis Holdings in Q3 2017 and held it in 10 quarters.
  • Yakira Capital Management's Organogenesis Holdings position peaked at $1.52M in Q3 2018.
  • 67 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2020.

Based on Yakira Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.